Head and neck cancer is the eighth most common malignancy and numbers are increasing. This has led to increasing number of suspected cancer referrals which, with imposition of the 28-day Faster Diagnosis Standard implemented in 2020, has further burdened the...
Developing safe, reliable and efficient ways to deliver therapeutics into the cochlea is a key challenge. In this article, the authors share their work to develop microneedles to address this challenge. The era of precision medicine of the inner ear...
Lufunda Lukama and Matthew Clark. Lufunda Lukama is an ENT surgeon in Zambia. In a country of 19.6 million, he is one of five such specialists. It is not difficult to see the problem that he, and the country as...
The opportunities provided by mhealth technologies to personalise and encourage user involvement in hearing healthcare has many benefits for adults with hearing loss. Melanie Ferguson explains how mhealth can empower hearing aid users. Connected health is likely to transform hearing...
Prof Valerie Lund caught up with friend and colleague, Prof Dr Metin Önerci, to discuss his various positions in rhinology, the FOAM programme with which he is involved, and rhinology in Turkey and the Balkan and the Central Asian region....
Vasant Oswal was, for many years, ‘Mister ENT’ in the Northeast of England. Appointed as a consultant to the old North Riding Infirmary in 1970, he led what was a small and little-known department through a period of tumultuous change...
This article explores the history of button batteries and how clinicians and industries alike could reduce the harm to children following ingestion. Following ingestion, if lodged, button batteries cause an alkaline reaction leading to necrosis of mucosa. Significant oesophageal injury...
The techniques for delivering drugs to the inner ear system are evolving. Jeffrey Harris considers the myths, the facts and the potential for drug delivery innovations and how they can improve tomorrow’s hearing outcomes. The inner ear’s delicate membranous structure,...
Being one of the few women professors of surgery in the world for most of my career inevitably led to some amusing situations. When I was first invited to the Middle East in the 1990s, I accepted primarily to see...
Brian Taylor provides an interesting perspective on market segmentation of the hearing impaired population, and how as clinicians and entrepreneurs we need to be able to recognise the different approaches that are required to address the large percentage of the...
Rhinosinusitis often follows radiotherapy in the treatment of carcinoma of the nasopharynx. The interval and severity may vary with the dose of radiation and stage of the carcinoma. In this randomised, controlled study, patients who developed rhinosinusitis after radiotherapy treatment...
Gene therapies for hearing loss are rapidly advancing and will be transitioning to clinical practice. Here, the authors explain why clinicians involved in managing these disorders need to be aware of these advances. Genomic testing in England was significantly reconfigured...